171 related articles for article (PubMed ID: 20010563)
1. Biotechs get $1 billion windfall in R&D tax credits.
Thiel K
Nat Biotechnol; 2009 Dec; 27(12):1066. PubMed ID: 20010563
[No Abstract] [Full Text] [Related]
2. New tax credit program aims to revive ailing biotech research.
Clin Transl Sci; 2010 Oct; 3(5):200. PubMed ID: 21500422
[No Abstract] [Full Text] [Related]
3. US biotech firms line up for tax credits.
Ledford H
Nature; 2010 Jun; 465(7300):854-5. PubMed ID: 20559355
[No Abstract] [Full Text] [Related]
4. Increasing number of companies found ineligible for SBIR funding.
Bouchie A
Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384
[No Abstract] [Full Text] [Related]
5. Chasing biotech, state by state--winners and losers.
Wilan KH
Nat Biotechnol; 2005 Feb; 23(2):175-9. PubMed ID: 15696143
[No Abstract] [Full Text] [Related]
6. China pushes liver proteomics.
Jia H; Louët S
Nat Biotechnol; 2004 Feb; 22(2):136. PubMed ID: 14755276
[No Abstract] [Full Text] [Related]
7. Germany contemplates new biotech tax scheme.
Mitchell P
Nat Biotechnol; 2003 Jun; 21(6):587-8. PubMed ID: 12776130
[No Abstract] [Full Text] [Related]
8. Federal stimulus adds momentum to sequencing stampede.
Fox JL
Nat Biotechnol; 2009 Dec; 27(12):1061-2. PubMed ID: 20010558
[No Abstract] [Full Text] [Related]
9. Little science, big bucks.
DeFrancesco L
Nat Biotechnol; 2003 Oct; 21(10):1127-9. PubMed ID: 14520387
[No Abstract] [Full Text] [Related]
10. Granting you success.
Beylin D; Chrisman CJ; Weingarten M
Nat Biotechnol; 2011 Jul; 29(7):567-70. PubMed ID: 21874663
[No Abstract] [Full Text] [Related]
11. Biotech parks proliferate, despite concerns over sustainability.
Jia H; Jayaraman KS; Orellana C
Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
[No Abstract] [Full Text] [Related]
12. The YIC factor.
Nat Biotechnol; 2005 Oct; 23(10):1187. PubMed ID: 16211041
[No Abstract] [Full Text] [Related]
13. Administrative costs for advance payment of health coverage tax credits: an initial analysis.
Dorn S
Issue Brief (Commonw Fund); 2007 Mar; 24():1-12. PubMed ID: 17419151
[TBL] [Abstract][Full Text] [Related]
14. Oh no! Not another acronym?
Wallner PE
J Am Coll Radiol; 2004 Sep; 1(9):629. PubMed ID: 17411670
[No Abstract] [Full Text] [Related]
15. Germany biotech gets second chance.
Sheridan C
Nat Biotechnol; 2003 Dec; 21(12):1414-5. PubMed ID: 14647310
[No Abstract] [Full Text] [Related]
16. Early experiences with federal health insurance tax credits.
Ix M
Find Brief; 2007 Sep; 10(7):1-3. PubMed ID: 17896428
[No Abstract] [Full Text] [Related]
17. Tax incentive for Australian research and development.
Andrew M
Australas Biotechnol; 1991 Oct; 1(2):87-8. PubMed ID: 1367646
[TBL] [Abstract][Full Text] [Related]
18. Brussels backs nanotech.
Nat Nanotechnol; 2007 Feb; 2(2):65. PubMed ID: 18654212
[No Abstract] [Full Text] [Related]
19. Ambitious French biotech plan faces EU hurdle.
Hodgson J
Nat Biotechnol; 2003 Feb; 21(2):113-4. PubMed ID: 12560821
[No Abstract] [Full Text] [Related]
20. US budget emphasizes bioterrorism countermeasures.
Fox JL
Nat Biotechnol; 2004 Mar; 22(3):256-7. PubMed ID: 14990938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
